- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-GM-CSF
GM-CSF Polyclonal Antibody for WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (3)
Applications
WB, IHC, IF, ELISA
Conjugaison
Non conjugué
N° de cat : 17762-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | NK-92 cells, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below |
| WB | See 20 publications below |
| IHC | See 12 publications below |
| IF | See 6 publications below |
Informations sur le produit
17762-1-AP cible GM-CSF dans les applications de WB, IHC, IF, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Réactivité citée | rat, Humain, souris, Hamster |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | GM-CSF Protéine recombinante Ag12142 |
| Nom complet | colony stimulating factor 2 (granulocyte-macrophage) |
| Masse moléculaire calculée | 144 aa, 16 kDa |
| Poids moléculaire observé | 15kDa,18 kDa ,22 kDa |
| Numéro d’acquisition GenBank | BC108724 |
| Symbole du gène | GM-CSF |
| Identification du gène (NCBI) | 1437 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony-stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, natural killer cells, endothelial cells and fibroblasts. GM-CSF is a hematopoietic growth factor that stimulates the development of early erythroid megakaryocytic and eosinophilic progenitor cells (PMID 2990035). GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes (PMID 3021817, 2984574, 6390681).
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for GM-CSF antibody 17762-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
J Hematol Oncol FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion | ||
Adv Sci (Weinh) Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy | ||
J Exp Med Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma. | ||
J Am Soc Nephrol Tubular GM-CSF Promotes Late MCP-1/CCR2-Mediated Fibrosis and Inflammation after Ischemia/Reperfusion Injury. | ||
Acta Pharmacol Sin Macrophages promote the transition from myocardial ischemia reperfusion injury to cardiac fibrosis in mice through GMCSF/CCL2/CCR2 and phenotype switching | ||
Oncogene CMAHP promotes metastasis by reducing ubiquitination of Snail and inducing angiogenesis via GM-CSF overexpression in gastric cancer. |
